TradingView
RocketTickers
Oct 27, 2021 7:55 PM

InflaRx Announces Positive Data from Third Cohort of Phase IIa O Long

NASDAQ:IFRX1D
InflaRx N.V.NASDAQ

Description

⋅
IFRX: InflaRx N.V.
2021-10-27 07:30:00
InflaRx Announces Positive Data from Third Cohort of Phase IIa Open-Label Study with Vilobelimab in Pyoderma Gangraenosum
Beyond Technical Analysis
More